| Tag | Content |
|---|
EnhancerAtlas ID | HS104-40384 |
Organism | Homo sapiens |
Tissue/cell | HUVEC |
Coordinate | chr3:46427360-46428260 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr3:46427752-46427773 | CTCTACTTTCACTTTTCTCTG | + | 6.56 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_25650 | chr3:46421412-46429186 | DND41 | | SE_29537 | chr3:46427543-46428506 | Fetal_Intestine_Large | | SE_43552 | chr3:46423866-46429119 | MM1S | | SE_62170 | chr3:46419501-46460269 | Toledo | | SE_67367 | chr3:46423866-46429119 | MM1S |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I046385 | chr3 | 46427407 | 46428701 |
|
Enhancer Sequence | AGCAGGGACT ACAGGCGCCC ACCACAACGC CTAGCTAATT TTTTGTATTT TCAGTAGAGA 60
TGGGGTTTCA CCATATTTTA TTTTATTTTT GAGACAGGGT CTCACTTTGT TGGCTCGCTG 120
CAACCTCTGC CTCCCAGGCT CAAGCAATCC TCCAACCTCA GCCCCCCAAG TAGCTGGGAG 180
GACAGACGTG CACCACCACA CCTGGCTAAT ATTTTGTATT TTTTTTTGTA GAGACAGGGT 240
CTTGCCATGT TCCCCAGGCT GGTCTTGAAC TCCTGGACTC AGGTGATCAG CCTGCCTCCA 300
CCTTCCAAAG TGCTAGGATT ACAGGAATGA GCCACCCCAC CCGACCACAC TCCCATTTCT 360
TGAGTGTGTG CATTTTGCTC TGCAATAAAT CTCTCTACTT TCACTTTTCT CTGACTCGTC 420
CTTGAATTCC TTCTTGTGAC AGCGTCAACA GCCTGGACAC CAGGTGCAGT CAACGTCTCA 480
CCAGTGTTTA GGGACCTCCC CTAATCCACT GGTATCAGCA TGATCAGACT TGCTTTTTCA 540
GAAAAAGCCT TCTGTCCATA GACCAAAGGG AAGTGACTCA GAGAAGGGGC AGGAGGAATC 600
ACAAGCTCCC TGCCTGACCA GGCCTGGACT ATGGCAGAGA CAGTGAGATG GTGAGAAAGC 660
AAGGGTAGAC AGCCAGCCAA ATCCAGAATA TAGAAAGTTC TACAGGAAAA GGTGGGGCCA 720
AGGTGGGACA GGGGGAAAGG AATTGTTGCA CATTAACAGT GCAATGCAGA GCACTGGTCT 780
TGTTTATGTC CAGGTTAGAA CAAACCAATG AGAAAGCACA TCTTTGAGAA AACTGGAGAA 840
ATTTGAACAC TGACTAGATA TAATATTATG TTAATTATGC TTTAATTTGG GGTACAATAA 900
|
